Redistribution of CD8+T cell subsets in metastatic renal cell carcinoma patients treated with anti-PD-1 therapy

被引:3
作者
De Biasi, Sara [1 ]
Guida, Annalisa [2 ,3 ]
Lo Tartaro, Domenico [1 ,4 ]
Fanelli, Martina [1 ,3 ]
Depenni, Roberta [3 ]
Dominici, Massimo [1 ,3 ]
Finak, Greg [5 ]
Porta, Camillo [6 ]
Paolini, Annamaria [1 ,4 ]
Borella, Rebecca [1 ,4 ]
Bertoldi, Carlo [7 ]
Cossarizza, Andrea [1 ,8 ]
Sabbatini, Roberto [3 ]
Gibellini, Lara [1 ]
机构
[1] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Emilia Romagna, Italy
[2] Azienda Osped Santa Maria, Terni, Italy
[3] Univ Modena & Reggio Emilia, Dept Oncol, Modena, Italy
[4] Univ Modena & Reggio Emilia, Clin & Expt Med PhD Program, Modena, Italy
[5] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[6] Univ Bari, Chair Oncol, Bari, Italy
[7] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, Emilia Romagna, Italy
[8] Natl Inst Cardiovasc Res, Bologna, Italy
关键词
anti-PD-1; therapy; mRCC; single-cells technologies; T cells; unsupervised cluster analysis; T-CELLS; NIVOLUMAB;
D O I
10.1002/cyto.a.24562
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Renal-cell carcinoma (RCC) is responsible for the majority of tumors arising from the kidney parenchyma. Although a progressive improvement in median overall survival has been observed after the introduction of anti-PD-1 therapy, many patients do not benefit from this treatment. Therefore, we have investigated T cell dynamics to find immune modification induced by anti-PD-1 therapy. Here, we show that, after therapy, RCC patients (5 responders and 14 nonresponders) are characterized by a redistribution of different subsets across the memory T cell compartment.
引用
收藏
页码:597 / 605
页数:9
相关论文
共 29 条
[1]   Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma [J].
Au, Lewis ;
Hatipoglu, Emine ;
de Massy, Marc Robert ;
Litchfield, Kevin ;
Beattie, Gordon ;
Rowan, Andrew ;
Schnidrig, Desiree ;
Thompson, Rachael ;
Byrne, Fiona ;
Horswell, Stuart ;
Fotiadis, Nicos ;
Hazell, Steve ;
Nicol, David ;
Shepherd, Scott T. C. ;
Fendler, Annika ;
Mason, Robert ;
Del Rosario, Lyra ;
Edmonds, Kim ;
Lingard, Karla ;
Sarker, Sarah ;
Mangwende, Mary ;
Carlyle, Eleanor ;
Attig, Jan ;
Joshi, Kroopa ;
Uddin, Imran ;
Becker, Pablo D. ;
Sunderland, Mariana Werner ;
Akarca, Ayse ;
Puccio, Ignazio ;
Yang, William W. ;
Lund, Tom ;
Dhillon, Kim ;
Vasquez, Marcos Duran ;
Ghorani, Ehsan ;
Xu, Hang ;
Spencer, Charlotte ;
Lopez, Jose, I ;
Green, Anna ;
Mahadeva, Ula ;
Borg, Elaine ;
Mitchison, Miriam ;
Moore, David A. ;
Proctor, Ian ;
Falzon, Mary ;
Pickering, Lisa ;
Furness, Andrew J. S. ;
Reading, James L. ;
Salgado, Roberto ;
Marafioti, Teresa ;
Jamal-Hanjani, Mariam .
CANCER CELL, 2021, 39 (11) :1497-+
[2]   Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma [J].
Bi, Kevin ;
He, Meng Xiao ;
Bakouny, Ziad ;
Kanodia, Abhay ;
Napolitano, Sara ;
Wu, Jingyi ;
Grimaldi, Grace ;
Braun, David A. ;
Cuoco, Michael S. ;
Mayorga, Angie ;
DelloStritto, Laura ;
Bouchard, Gabrielle ;
Steinharter, John ;
Tewari, Alok K. ;
Vokes, Natalie, I ;
Shannon, Erin ;
Sun, Maxine ;
Park, Jihye ;
Chang, Steven L. ;
McGregor, Bradley A. ;
Haq, Rizwan ;
Denize, Thomas ;
Signoretti, Sabina ;
Guerriero, Jennifer L. ;
Vigneau, Sebastien ;
Rozenblatt-Rosen, Orit ;
Rotem, Asaf ;
Regev, Aviv ;
Choueiri, Toni K. ;
Van Allen, Eliezer M. .
CANCER CELL, 2021, 39 (05) :649-+
[3]   Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma [J].
Choueiri, T. K. ;
Powles, T. ;
Burotto, M. ;
Escudier, B. ;
Bourlon, M. T. ;
Zurawski, B. ;
Juarez, V. M. Oyervides ;
Hsieh, J. J. ;
Basso, U. ;
Shah, A. Y. ;
Suarez, C. ;
Hamzaj, A. ;
Goh, J. C. ;
Barrios, C. ;
Richardet, M. ;
Porta, C. ;
Kowalyszyn, R. ;
Feregrino, J. P. ;
Zolnierek, J. ;
Pook, D. ;
Kessler, E. R. ;
Tomita, Y. ;
Mizuno, R. ;
Bedke, J. ;
Zhang, J. ;
Maurer, M. A. ;
Simsek, B. ;
Ejzykowicz, F. ;
Schwab, G. M. ;
Apolo, A. B. ;
Motzer, R. J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09) :829-841
[4]   Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) [J].
Cossarizza, Andrea ;
Chang, Hyun-Dong ;
Radbruch, Andreas ;
Abrignani, Sergio ;
Addo, Richard ;
Akdis, Muebeccel ;
Andrae, Immanuel ;
Andreata, Francesco ;
Annunziato, Francesco ;
Arranz, Eduardo ;
Bacher, Petra ;
Bari, Sudipto ;
Barnaba, Vincenzo ;
Barros-Martins, Joana ;
Baumjohann, Dirk ;
Beccaria, Cristian G. ;
Bernardo, David ;
Boardman, Dominic A. ;
Borger, Jessica ;
Boettcher, Chotima ;
Brockmann, Leonie ;
Burns, Marie ;
Busch, Dirk H. ;
Cameron, Garth ;
Cammarata, Ilenia ;
Cassotta, Antonino ;
Chang, Yinshui ;
Chirdo, Fernando Gabriel ;
Christakou, Eleni ;
Cicin-Sain, Luka ;
Cook, Laura ;
Corbett, Alexandra J. ;
Cornelis, Rebecca ;
Cosmi, Lorenzo ;
Davey, Martin S. ;
De Biasi, Sara ;
De Simone, Gabriele ;
del Zotto, Genny ;
Delacher, Michael ;
Di Rosa, Francesca ;
Di Santo, James ;
Diefenbach, Andreas ;
Dong, Jun ;
Doerner, Thomas ;
Dress, Regine J. ;
Dutertre, Charles-Antoine ;
Eckle, Sidonia B. G. ;
Eede, Pascale ;
Evrard, Maximilien ;
Falk, Christine S. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (12) :2708-3145
[5]   Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia [J].
De Biasi, Sara ;
Meschiari, Marianna ;
Gibellini, Lara ;
Bellinazzi, Caterina ;
Borella, Rebecca ;
Fidanza, Lucia ;
Gozzi, Licia ;
Iannone, Anna ;
Lo Tartaro, Domenico ;
Mattioli, Marco ;
Paolini, Annamaria ;
Menozzi, Marianna ;
Milic, Jovana ;
Franceschi, Giacomo ;
Fantini, Riccardo ;
Tonelli, Roberto ;
Sita, Marco ;
Sarti, Mario ;
Trenti, Tommaso ;
Brugioni, Lucio ;
Cicchetti, Luca ;
Facchinetti, Fabio ;
Pietrangelo, Antonello ;
Clini, Enrico ;
Girardis, Massimo ;
Guaraldi, Giovanni ;
Mussini, Cristina ;
Cossarizza, Andrea .
NATURE COMMUNICATIONS, 2020, 11 (01)
[6]   Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors [J].
Gibellini, Lara ;
De Biasi, Sara ;
Porta, Camillo ;
Lo Tartaro, Domenico ;
Depenni, Roberta ;
Pellacani, Giovanni ;
Sabbatini, Roberto ;
Cossarizza, Andrea .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[7]   Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers [J].
Hopkins, Ashley M. ;
Rowland, Andrew ;
Kichenadasse, Ganessan ;
Wiese, Michael D. ;
Gurney, Howard ;
McKinnon, Ross A. ;
Karapetis, Chris S. ;
Sorich, Michael J. .
BRITISH JOURNAL OF CANCER, 2017, 117 (07) :913-920
[8]   T-cell invigoration to tumour burden ratio associated with anti-PD-1 response [J].
Huang, Alexander C. ;
Postow, Michael A. ;
Orlowski, Robert J. ;
Mick, Rosemarie ;
Bengsch, Bertram ;
Manne, Sasikanth ;
Xu, Wei ;
Harmon, Shannon ;
Giles, Josephine R. ;
Wenz, Brandon ;
Adamow, Matthew ;
Kuk, Deborah ;
Panageas, Katherine S. ;
Carrera, Cristina ;
Wong, Phillip ;
Quagliarello, Felix ;
Wubbenhorst, Bradley ;
D'Andrea, Kurt ;
Pauken, Kristen E. ;
Herati, Ramin S. ;
Staupe, Ryan P. ;
Schenkel, Jason M. ;
McGettigan, Suzanne ;
Kothari, Shawn ;
George, Sangeeth M. ;
Vonderheide, Robert H. ;
Amaravadi, Ravi K. ;
Karakousis, Giorgos C. . ;
Schuchter, Lynn M. ;
Xu, Xiaowei ;
Nathanson, Katherine L. ;
Wolchok, Jedd D. ;
Gangadhar, Tara C. ;
Wherry, E. John .
NATURE, 2017, 545 (7652) :60-+
[9]   Cancer Statistics, 2010 (vol 60, pg 277, 2010) [J].
Jemal, A. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (02) :134-134
[10]   Transcription Factor T-bet Orchestrates Lineage Development and Function in the Immune System [J].
Kallies, Axel ;
Good-Jacobson, Kim L. .
TRENDS IN IMMUNOLOGY, 2017, 38 (04) :287-297